Stifel Nicolaus Maintains Buy on Principia Biopharma, Raises Price Target to $66

Stifel Nicolaus maintains Principia Biopharma (NASDAQ:PRNB) with a Buy and raises the price target from $51 to $66.

Benzinga · 12/19/2019 14:47

Stifel Nicolaus maintains Principia Biopharma (NASDAQ:PRNB) with a Buy and raises the price target from $51 to $66.